FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

429611006: Lanreotide acetate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2008. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2691550013 Lanreotide acetate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2692194013 Lanreotide acetate en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lanreotide acetate Is a Lanreotide false Inferred relationship Existential restriction modifier
Lanreotide acetate Has disposition Hypothalamic inhibiting factor true Inferred relationship Existential restriction modifier
Lanreotide acetate Is a Somatostatin analog true Inferred relationship Existential restriction modifier
Lanreotide acetate Is modification of Lanreotide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lanreotide 120mg/0.5mL prefilled syringe Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 60mg/0.3mL prefilled syringe Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 90mg/0.3mL prefilled syringe Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for injection suspension vial Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Product containing precisely lanreotide (as lanreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection Has precise active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely lanreotide (as lanreotide acetate) 180 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely lanreotide (as lanreotide acetate) 120 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely lanreotide (as lanreotide acetate) 240 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier 1
Lanreotide 120mg/0.5ml solution for injection pre-filled syringes (Advanz Pharma) Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 120mg/0.5ml solution for injection pre-filled syringes (Advanz Pharma) 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 60mg/0.5ml solution for injection pre-filled syringes (Advanz Pharma) 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 90mg/0.5ml solution for injection pre-filled syringes (Advanz Pharma) Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 90mg/0.5ml solution for injection pre-filled syringes (Advanz Pharma) 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 60mg/0.5ml solution for injection pre-filled syringes (Advanz Pharma) Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 60mg/0.3ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 60mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd) Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 60mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd) 1 pre-filled disposable injection Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 90mg/0.3ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 90mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd) Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 90mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd) 1 pre-filled disposable injection Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 120mg/0.5ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 120mg/0.5ml solution for injection pre-filled syringes (Ipsen Ltd) Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 120mg/0.5ml solution for injection pre-filled syringes (Ipsen Ltd) 1 pre-filled disposable injection Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 60mg/0.3ml solution for injection pre-filled syringes Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 120mg/0.5ml solution for injection pre-filled syringes Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 90mg/0.3ml solution for injection pre-filled syringes Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Has active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 90mg/0.3ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 90mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd) Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 90mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd) 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 90mg/0.3ml solution for injection pre-filled syringes Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 120mg/0.5ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 120mg/0.5ml solution for injection pre-filled syringes Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 120mg/0.5ml solution for injection pre-filled syringes (Ipsen Ltd) Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 120mg/0.5ml solution for injection pre-filled syringes (Ipsen Ltd) 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 60mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd) Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 60mg/0.3ml solution for injection pre-filled syringes Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 60mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd) 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 60mg/0.3ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for injection suspension vial Has specific active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 60mg/0.5ml solution for injection pre-filled syringes Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 90mg/0.5ml solution for injection pre-filled syringes Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 60mg/0.5ml solution for injection pre-filled syringes with safety system (Ipsen Ltd) Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 90mg/0.5ml solution for injection pre-filled syringes with safety system (Ipsen Ltd) Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 120mg/0.5ml solution for injection pre-filled syringes with safety system (Ipsen Ltd) Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 90mg/0.5ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 60mg/0.5ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 60mg/0.5ml solution for injection pre-filled syringes with safety system (Ipsen Ltd) 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 90mg/0.5ml solution for injection pre-filled syringes with safety system (Ipsen Ltd) 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Somatuline Autogel 120mg/0.5ml solution for injection pre-filled syringes with safety system (Ipsen Ltd) 1 pre-filled disposable injection Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Has specific active ingredient False Lanreotide acetate Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Has specific active ingredient True Lanreotide acetate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start